Issue 12 2020 15 Centre of Approachability and Collaboration Butterfield is a leading, independent offshore bank and trust company, providing a full range of community banking and wealth management services in Bermuda and the Cayman Islands, and specialised financial services for private clients and intermediaries from six additional financial centres around the world. Mark Johnson, Vice President, tells us more. Steeped in a history spanning over two centuries, Butterfield originated from a family dry goods business which was established in Bermuda in 1784. Originally specialising in shipping Bermuda cedar, salt and wine, the firm eventually began maintaining current accounts for its clientele. By the early 1800s, financial transactions came to dominate the daily business of the company and in 1858, it was established as a private bank in Bermuda by Nathaniel T. Butterfield, and later incorporated under a special act of the local Parliament in 1904. Today, Butterfield provides a range of banking, wealth management and trust services to clients from offices in The Bahamas, Bermuda, the Cayman Islands, Guernsey, Jersey, Singapore, Switzerland and the United Kingdom. The firm has been publicly traded on the Bermuda Stock Exchange since 1971 (symbol NTB.BH) , and it expanded its ownership base in 2016 with a listing on the New York Stock Exchange (symbol NTB), where it is one of the oldest companies trading. Today, with a vision to be the world’s leading, independent offshore bank and trust company, and a mission to build relationships and wealth, Butterfield prides itself on being approachable and works collaboratively across teams and with clients and their advisers to create bespoke financial solutions. Vice President, Mark Johnson, touches on the firm’s strategy, which aims to promote long-term growth whilst maintain strong capital and liquidity. “A central tenet of the strategy is to build upon our relationship-based business approach by delivering exceptional client services,” he explains. “Relative to larger international banks, our service is high-touch, and the solutions we deliver tend to be more customised. “In Bermuda and the Cayman Islands, we deliver a full range of banking, trust and investment services to personal and corporate clients. In the Channel Islands, our banking business is more specialised,” states Mark. “It comprises services primarily for financial intermediaries. In the UK, Butterfield operates exclusively as a bespoke mortgage lender for premium properties in Central London and the home counties, and across The Bahamas, Bermuda, the Cayman Islands, Sep20660 Guernsey, Switzerland and Singapore, it operates subsidiary trust companies providing fiduciary services to HNW international families focused on securing, growing and making provisions for the inter- generational transfer of wealth.” Butterfield is a very client-centric organisation that does not rely on cookie-cutter lending or investment approaches. It draws upon resources and knowledge from across its international network to curate solutions for clients. This necessitates a high degree of collaboration among the professional banking, trust and investment teams. In fact, as Mark explains further, Butterfield’s staff base is an important asset. “Employees are encouraged to be innovative in their approach to curating solutions for clients, and work together as a team to bring those solutions to fruition. “Our front-line employees, who forge the relationships with clients and their advisers, are the key to business development and our ongoing success. Our mid-office and back office personnel who ensure that we are able to fulfil our obligations to clients, as well as process their business efficiently and effectively, are the key to enabling us to maintain those relationships and build trust with clients over generations. “We look for employees who demonstrate our core values of approachable, collaborative, empowered and impactful; those who focus on the needs of clients.” As a financial institution that operates primarily from offshore locations, Butterfield is highly focused on ensuring that it is a leader in compliance, ensuring that it meets or exceeds all local and international standards for AML/ATF, KYC, tax compliance and reporting. “It is our duty to our stakeholders to maintain the reputation of the Bank and by extension, the reputations of the jurisdictions in which we operate, as transparent, cooperative and well-regulated. Compliance is the most important thing we do each day. “Regarding the future, with our communities facing economic challenges stemming from the impact of the pandemic, and interest rates expected to be low for an extended period, Butterfield is focused on maintaining excellence in client service, whilst finding and executing on opportunities for improved operational efficiency. “Thoughtful expansion through trust and banking acquisitions in premier offshore jurisdictions where we understand the regulatory and business environment will also continue to be considered over the longer term.” Contact: Mark Johnson Web Address: www.butterfieldgroup.com care of the R3 team, who are flexible and amenable, always willing to go the extra mile for their patients and clients. R3 is looking ahead, with ambitious plans for the next few years. Currently working with more than forty Centers of Excellence across the US and four Internationally, the goal is to expand their client base even further, allowing more patients to receive therapies, both nationally and internationally. R3 is also investing in the expansion of R3 Medical Training to enable them to provide regenerative therapies for military veterans through the R3 Heroes Program, which has already helped over a hundred veterans to date receive free stem cell treatments. There is no doubt that R3 will be one to watch over the years to come. Contact: David Greene, MD, MBA Email:
[email protected] Web Address: www.r3stemcell.com Regenerating Tomorrow R3 Stem Cell is on a mission to change the lives of patients across the US and beyond, offering regenerative medicine therapies intended to repair, regenerate and restore damaged tissue. By harnessing the body’s regenerative capabilities, R3 offers patients the option to avoid surgery, reduce pain by healing rather than suppressing, and to take back their active lifestyles. As a company at the forefront of regenerative therapies, R3 is also investing heavily in education and research behind stem cell regeneration, increasing awareness and accessibility to this lifechanging therapy. R3 Stem Cell is a leading US-based regenerative therapies company, offering comprehensive services to medical practices and providers including marketing, training, education, research and first-class biologics. R3 is a ground-breaking regenerative medicine ‘add-on’ to an existing medical practice, that offers cutting-edge stem cell procedures designed to improve patient outcomes and generate new revenue streams. Having performed over 15,000 regenerative procedures since the company’s inception, R3 has always been committed to providing cutting edge therapies designed to promote the possibility of repairing, regenerating and restoring damaged tissue. The result is to reduce pain and increase functional abilities in patients, with the potential to avoid high-risk and invasive surgeries. Thanks to first-rate biologics and treatment protocols, patients can often reclaim their pain-free and active lifestyles. In what is becoming an increasingly competitive market, R3 stands out for its investment in marketing and education for patient and providers, quality biologics, extensive peer-to-peer network and IRB Approved protocols. Working with providers who come from backgrounds as MDs, DOs, DSs, NPs, NMDs, DDSs, Aestheticians, PA’s and more, R3 can work with most medical providers to implement first-rate regenerative campaigns. For a long time, stem cell therapy has been unrecognized or mistrusted owing to lack of information in the US. R3 has therefore dedicated its efforts to consumer education, explaining what this cutting-edge technology can do for them, and creating realistic expectations that are conducive to positive outcomes. In addition, R3 is the only company nationwide to offer a Therapy Commitment, meaning if a clinic performs a procedure with R3 biologics and the patient is unhappy after a year, the company will perform another procedure for free. The procedure will be performed at one of its training workshops by their expert trainers. The increasing popularity of regenerative therapies has led to an increase in the offering of R3’s services, working with medical providers who seek to become trained in R3 therapy. As a result, R3 Medical Training was established several years ago. Through webinars, social media, educational videos and their excellent in person training workshops, R3 can equip their clients with patient marketing and scheduling, patient education and provider training, an extensive network of peers, first-rate biologics from cGMP compliant labs, IRB Approved protocols and more. The training program has proved an immensely successful way to give providers complete knowledge of biologics and procedure techniques. At the training workshops, providers learn how to perform regenerative procedures, vital information on stem cell and exosome biologics, along with being able to have a stem cell procedure as well! While R3 would not be able to operate without their innovative biologics, it is the staff that has been fundamental to the organization’s growth and success. Operating as a distributed workforce on an international scale, R3 has cultivated a culture of talent without boundaries, unified in their vision to help patients attain a better quality of life. Although managed by Dr David Greene, the staff are trusted to manage their own cases and projects, collaborating and thinking creatively to produce positive outcomes for patients and clients alike. The positive feedback of R3 medical providers is a testament to the outstanding and conscientious Sep20437 Corporate Excellence Awards 95